IndraLab

Statements



reach
"JOSD2 has been shown to promote non-small cell lung cancer (NSCLC) cell proliferation by stabilizing metabolic enzymes aldolase A and phosphofructokinase-1, suggesting that JOSD2 is a positive regulator of glucose metabolism [4]."

reach
"The results showed that JOSD2 overexpression significantly promoted the proliferation (P < 0.0001), drug resistance (P < 0.0001), migration (P < 0.01), and invasion (P < 0.001) capability of KYSE30 cells (Figure 5C-E)."

reach
"JOSD2 promotes ESCC cell proliferation and drug resistance in vivo."

reach
"In vivo xenograft assays confirmed that JOSD2 promoted tumor proliferation and drug resistance in ESCC."

reach
"The depletion of JOSD2 significantly impaired the proliferation of CCA cells."

reach
"JOSD2 promotes cell proliferation, migration, and drug resistance in ESCC."

reach
"As expected, JOSD2 overexpression significantly promoted cell proliferation of LKB-WT NSCLC cells NCI-H1299 and PC-9, with no appreciable change in LKB-null cells A549 and NCI-H460 (Fig. 5a–d)."

reach
"Correspondingly, JOSD2 depletion significantly inhibited the cell proliferation in these NSCLC cells harboring LKB-WT (Fig. 1e), whereas imposed a weaker effect on LKB-null cells A549 cells at least under our experimental condition (Supplementary Fig. S7d, e)."

reach
"We found that JOSD2 depletion by RNA interference robustly inhibited the proliferation of both PDC cells in vitro (Fig. 6b), accompanied with the activation of p-LKB (Supplementary Fig. S8a)."

reach
"JOSD2 deficiency inhibits tumor cell proliferation by reducing glycolysis, and its mRNA expression is related to the worst prognosis in NSCLC (Krassikova et al., 2021)."

reach
"We first examined the effects of JOSD2 knockdown on KRAS-mutant CRC cell growth and found depletion of JOSD2 dramatically inhibited the proliferation and colony formation of KRAS-mutant CRC cells SW480, SW620, and HCT-116 in vitro (Supplementary Fig. 3a–d)."

reach
"Taken together, these data confirmed that depletion of JOSD2 significantly arrested the NSCLC cell proliferation in vitro and tumor growth in vivo."

reach
"Subsequent analyses revealed that JOSD2 significantly enhanced the proliferation, migration, and drug resistance of ESCC cells."

reach
"For cancer types that are highly reliant on glycolysis for their energy supply, increased JOSD2 expression significantly promoted cell proliferation and growth."

reach
"These results collectively indicate that YAP/TAZ have critical roles in CCA proliferation and JOSD2 is a potential oncogenic DUB in YAP/TAZ-related CCA.3.2 JOSD2 promotes CCA cells proliferation and stabilizes YAP/TAZ proteins."

reach
"Moreover, depletion of JOSD2 notably inhibited KRAS-mutant NSCLC cell proliferation, which is consistent with the results observed in KRAS-mutant CRC."

reach
"JOSD2 knockdown inhibited ESCC cell activity, including proliferation and colony-forming ability."

reach
"In vivo xenograft assays further confirmed that JOSD2 promoted tumor proliferation and drug resistance in ESCC."

reach
"JOSD2 enhances ESCC cell proliferation, drug resistance, and migration in vitro."